Deal Boosts Gene-Editing Technology Aiming to Cure Type 1 Diabetes
Frontiers | Stem Cell-Based Clinical Trials for Diabetes Mellitus
In a new stem cell study, a cure for Type 1 diabetes appears tantalizingly close | Salon.com
Vertex's Stem Cell-Based Type 1 Diabetes Therapy To Enter Human Trial Stage | The Healthcare Technology Report.
Vertex Pharmaceuticals am 52-Wochenhoch – Studie für Stammzellentherapie gegen Diabetes-Typ-1 wird fortgesetzt!
JDRF Report: Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex cell therapy lets patients with type 1 diabetes stop insulin
Vertex signs licence deal with CRISPR for diabetes therapies
Vertex Releases New Data on Potential Cure for Type 1 Diabetes
Vertex's Groundbreaking Therapy for Type 1 Diabetes | VX-880 - YouTube
Vertex – type 1 diabetes vs stem cell therapy - The Boar
New Vertex Type 1 Stem Cell Therapy Gets FDA Nod to Enter Clinical Trials
Can Vertex Pharmaceuticals and Douglas Melton CURE Type 1 Diabetes? | VX880 - YouTube
Type 1 Diabetes Stem Cell Therapy Gets Greenlight for Human Trials
FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes
Vertex: Trial of New Type 1 Diabetes Cell Therapy Put on Hold - DSM
Vertex: New Stem Cell Based Type 1 Diabetes Treatment Shown Effective in First Patient - DSM
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech | Evaluate
Vertex reports positive results for first patient in Type 1 diabetes trial - The Boston Globe
Vertex's Type 1 diabetes med back on track after FDA hold lifted
Vertex to acquire ViaCyte, targeting type 1 diabetes
The First Man CURED of Type 1 Diabetes | VX-880 - YouTube
Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82. Scientific Sessions der American Diabetes Association | Business Wire
Vertex's diabetes treatment hit with FDA hold
